AXS-12, known as reboxetine back when it was available as an antidepressant in the United States, may decrease cataplexy ...

本综述深入探讨了发作性睡病（Narcolepsy）的临床表现、治疗策略及未来方向，强调需超越经典五联征进行综合管理。 发作性睡病（Narcolepsy）是一种罕见的慢性神经学疾病，其特征性症状包括白天过度嗜睡（Excessive Daytime Sleepiness, EDS）、猝倒（Cataplexy）、夜间 ...

These results show that Provigil is effective for reducing excessive daytime sleepiness in people with narcolepsy. People taking Provigil had lower sleepiness scores than people taking a placebo.

For the next in our series of conditions GPs might rarely encounter, Neurology consultant Dr Clare Bolton provides an ...

Failure to get enough rest puts lives in danger and leads to a litany of long-term health issues, the American Academy of ...

Excessive daytime sleepiness, or hypersomnia ... If it’s idiopathic or related to sleep-wake disorders, such as narcolepsy, stimulant medications may help you stay awake during the day.

The American Academy of Sleep Medicine has released a new position statement emphasizing the clinical significance of sleepiness and its impact on performance, health, mood, safety, and quality of ...

From baseline, patients treated with AXS-12 had an 83% reduction in cataplexy attacks at the end of 5 weeks compared with a ...

Among patients with narcolepsy, AXS-12 (reboxetine) vs placebo significantly reduced the frequency of cataplexy attacks.

Explore the hidden dangers of excessive yawning and sleep deprivation. Learn how insufficient sleep can affect your health, behavior, and cognitive functioning, and discover expert recommendations to ...

Results were announced from a phase 3 trial evaluating solriamfetol for major depressive disorder with/without severe excessive daytime sleepiness.